Anticardiolipin Antibodies Predict Early Recurrence of Thromboembolism and Death Among Patients with Venous Thromboembolism Following Anticoagulant Therapy

The management of thrombosis in the antiphospholipid-antibody syndrome

Khamashta, M. A., Cuadrado, M. J., Mujic, F., Taub, N. A., Hunt, B. J., & Hughes, G. R. V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321504 · Cited by 1,450

A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism

Schulman, S., Rhedin, A.-S., Lindmarker, P., Carlsson, A., Lärfars, G., Nicol, P., Loogna, E., Svensson, E., Ljungberg, B., Walter, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506223322501 · Cited by 932

Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients

Rosove, M. H., & Brewer, P. M. C. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-303 · Cited by 700

The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism

Schulman, S., Granqvist, S., Holmström, M., Carlsson, A., Lindmarker, P., Nicol, P., Eklund, S. ‐., Nordlander, S., Lärfars, G., Leijd, B., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702063360601 · Cited by 595

Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis

Ginsburg, K. S., Liang, M. H., Newcomer, L., Goldhaber, S. Z., Schur, P. H., Hennekens, C. H., & Stampfer, M. J. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-997 · Cited by 526

Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patients

Vianna, J. L., Khamashta, M. A., Ordi, J., Font, J. A., Cervera, R., López‐Soto, A., Tolosa, C., Franz, J. K., Selva-O’Callaghan, A., Ingelmo, M., et al. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90108-2 · Cited by 466

Antiphospholipid Antibodies and venous thromboembolism

Ginsberg, J., Wells, P., Brill-Edwards, P., Donovan, D., Moffatt, K., Johnston, M., Stevens, P., & Hirsh, J. (1995) · Blood · doi:10.1182/blood.v86.10.3685.bloodjournal86103685 · Cited by 365

ANTIBODIES TO CARDIOLIPIN IN YOUNG SURVIVORS OF MYOCARDIAL INFARCTION: AN ASSOCIATION WITH RECURRENT CARDIOVASCULAR EVENTS

Hamsten, A., Björkholm, M., Norberg, R., Fairé, U. D., & Holm, G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92258-0 · Cited by 356

LACTATE AS ENERGY SOURCE FOR BRAIN IN GLUCOSE-6-PHOSPHATASE DEFICIENT CHILD

Fernandes, J., Berger, R. M. F., & Smit, G. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90257-4 · Cited by 319

Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment.

Derksen, R. H. W. M., de Groot, P. G., Kater, L., & Nieuwenhuis, H. K. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.9.689 · Cited by 240

Antiphospholipid Syndrome in Patients with Venous Thromboembolism

Pengo, V., & Denas, G. (2022) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0042-1749590 · Cited by 8

Laboratory Evaluation of Thrombophilia

Marlar, R. A. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3175-1_10 · Cited by 8

Long-Term Anticoagulation Prophylaxis Following Acute Thromboembolism

Hyers, T. M. (2005) · Disease-a-Month · doi:10.1016/j.disamonth.2005.03.011 · Cited by 8

The antiphospholipid antibody syndrome

Nimmo, M., & Carter, C. J. (2003) · Clinical and Applied Immunology Reviews · doi:10.1016/s1529-1049(03)00047-3 · Cited by 8

Anticoagulation Therapy in Children

Ronghe, M., Halsey, C., & Goulden, N. (2003) · Pediatric Drugs · doi:10.2165/00148581-200305120-00004 · Cited by 8

Thrombin generation as marker to estimate thrombosis risk in patients with abnormal test results in lupus anticoagulant routine diagnostics

Boeer, K., Cuznetov, L., & Loesche, W. (2013) · Thrombosis Journal · doi:10.1186/1477-9560-11-24 · Cited by 8

Treatment and monitoring of patients with antiphospholipid antibodies and thrombotic history (hughes syndrome)

Cuadrado, M. J. (2002) · Current Rheumatology Reports · doi:10.1007/s11926-002-0083-0 · Cited by 8

Nephrological and obstetric complications of the antiphospholipid syndrome

Nickolas, T. L., Radhakrishnan, J., & Isom, R. T. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.6.819 · Cited by 8

Pulmonary Hypertension and Antiphospholipid Antibodies

Pietté, J. C., & Hunt, B. J. (2000) · Springer eBooks · doi:10.1007/978-1-4471-3666-8_10 · Cited by 8

Diagnosis and Anticoagulant Treatment

Nicolaides, A. N., Fareed, J., Kakkar, A. K., Comerota, A. J., Goldhaber, S. Z., Hull, R., Myers, K., Samama, M. M., Fletcher, J. M., Kalodiki, E., et al. (2013) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029612474840n · Cited by 7

Management of the antiphospholipid syndrome

Espinosa, G., & Cervera, R. (2010) · Autoimmunity Highlights · doi:10.1007/s13317-010-0004-6 · Cited by 7

Progression of antiphospholipid antibody syndrome to catastrophic antiphospholipid antibody syndrome acutely with cessation of antithrombotic therapy

Katikireddi, V. S., & Kandiah, D. A. (2012) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2012.02768.x · Cited by 7

Estrategias terapéuticas en el síndrome antifosfolipídico

Cervera, R. (2009) · Reumatología Clínica · doi:10.1016/j.reuma.2008.11.020 · Cited by 8

Anticoagulation for Noncardiac Indications in Neurologic Patients: Comparative Use of Non-Vitamin K Oral Anticoagulants, Low-Molecular-Weight Heparins, and Warfarin

Marshall, A. L., & Connors, J. M. (2014) · Current Treatment Options in Neurology · doi:10.1007/s11940-014-0309-2 · Cited by 7

Antiphospholipid syndrome: Unusual clinical presentations

Greaves, M. (2011) · Thrombosis Research · doi:10.1016/s0049-3848(11)70013-5 · Cited by 7

Antiphospholipid (Hughes) Syndrome: An Overview

D’Cruz, D. P. (2006) · Springer eBooks · doi:10.1007/1-84628-009-5_2 · Cited by 7

Letale Sinusvenenthrombose bei einer Patientin mit Mischkollagenose und sekundärem Antiphospholipid-Antikörper-Syndrom

Glück, T., Müller‐Ladner, U., Speicher, A., Pickenpack, A., Röckelein, G., & Schölmerich, J. (2001) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-001-1059-y · Cited by 7

Thrombophilia Screening

Hornsby, L. B., Armstrong, E. M., Bellone, J. M., Eudaley, S. T., & Phillippe, H. M. (2014) · Journal of Pharmacy Practice · doi:10.1177/0897190014530426 · Cited by 7

Treatment of Antiphospholipid Syndrome

Espinosa, G., & Cervera, R. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-374994-9.10055-5 · Cited by 7

Applications of Coumarins as Cardiovascular and Anti-Cancer Agents: A Short Review

Shejwalkar, P. (2017) · Journal of Cardiology & Cardiovascular Therapy · doi:10.19080/jocct.2017.08.555749 · Cited by 7

Trends of anticardiolipin antibodies after low-dose methylprednisolone and cyclophosphamide treatment of systemic lupus erythematosus

Lavalle-Graef, A., Villegas-Acosta, L., & Lavalle, C. M. (2004) · Archives of Medical Research · doi:10.1016/j.arcmed.2004.05.006 · Cited by 7

Venous thromboembolism in men and women

Kyrle, P. A., & Eichinger, S. (2005) · The Journal of Men s Health and Gender · doi:10.1016/j.jmhg.2005.04.002 · Cited by 7

Evidence-based treatment of the antiphospholipid syndrome

Wislöff, F., & Crowther, M. A. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.05.006 · Cited by 7

Anticoagulation therapy in the antiphospholipid syndrome: recent advances

Ng, H. J., & Crowther, M. A. (2005) · Current Opinion in Pulmonary Medicine · doi:10.1097/01.mcp.0000174229.24854.2e · Cited by 7

Antiphospholipid antibody syndrome

Cucurull, E., Gharavi, A. E., Menon, Y., & Wilson, W. A. (2003) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-003-0021-0 · Cited by 7

Examining the non-linear relationship between monoclonal antiphospholipid antibody sequence, structure and function

Giles, I., Lambrianides, A., & Rahman, A. (2008) · Lupus · doi:10.1177/0961203308091541 · Cited by 7

Heart Disease, Pregnancy and Systemic Autoimmune Diseases

Ruiz‐Irastorza, G., Khamashta, M. A., & Hughes, G. R. V. (2007) · Wiley eBooks · doi:10.1002/9780470994955.ch11 · Cited by 7

In vivo characterization of bioconjugate B cell toleragens with specificity for autoantibodies in antiphospholipid syndrome

Cockerill, K. A., Smith, E., Jones, D. S., Branks, M. J., Hayag, M. S., Victoria, E. J., Linnik, M. D., & Campbell, M.-A. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(03)00203-0 · Cited by 7

The Antiphospholipid Syndrome

Breen, K. A. (2017) · Wiley eBooks · doi:10.1002/9781119095606.ch8 · Cited by 7

Guidelines on deep vein thrombosis of the Brazilian Society of Angiology and Vascular Surgery

Sobreira, M. L., Marques, M. A., Paschôa, A. F., Ribeiro, A. J. A., Casella, I. B., Burihan, M. C., Matielo, M. F., Soares, R. D. A., de Araújo, W. J. B., Joviliano, E. É., et al. (2024) · Jornal Vascular Brasileiro · doi:10.1590/1677-5449.202301072 · Cited by 6

Recurrent venous thrombosis despite 'optimal anticoagulation therapy' for antiphospholipid syndrome--could new oral anticoagulants solve the problem?

Balaban, M., Stanrić, V., Rinčić, G., Ledinsky, M., Grbac, L., Stančić, N., & Tomasić, H. (2010) · PubMed · Cited by 6

Therapeutic strategies in antiphospholipid syndrome

Cervera, R. (2010) · Reumatología Clínica (English Edition) · doi:10.1016/s2173-5743(10)70007-1 · Cited by 6

Pathogenesis and management of antiphospholipid syndrome

Greaves, M. (2009) · Thrombosis Research · doi:10.1016/s0049-3848(09)70002-7 · Cited by 7

Thrombophilia

Freed, J. A., & Bauer, K. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-46202-0.00014-5 · Cited by 6

The Antiphospholipid Syndrome

D’Cruz, D. P., Knight, J. S., Sammaritano, L. R., Salmon, J. E., Cervera, R., & Khamashta, M. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-23488-0_14 · Cited by 6

Venous Thromboembolism

Schellong, S., Bounameaux, H., & Buller, H. R. (2009) · doi:10.1093/med/9780199566990.003.037 · Cited by 6

Duration of anticoagulants in acute or recurrent venous thromboembolism

Schulman, S. (2000) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-200007000-00012 · Cited by 6

Durée optimale du traitement anticoagulant au décours d’une embolie pulmonaire

Couturaud, F. (2011) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2011.04.017 · Cited by 5

Hypercoagulable State

Schafer, A. I. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_117 · Cited by 5

A Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous Thromboembolism

(1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410423 · Cited by 5

Anticoagulant Treatment of Deep Vein Thrombosis and Pulmonary Embolism

Tran, H. A., McRae, S. J., & Ginsberg, J. S. (2008) · Cardiology Clinics · doi:10.1016/j.ccl.2007.12.006 · Cited by 5

Management of Thrombosis in the Antiphospholipid Syndrome

Khamashta, M. A. (2000) · Springer eBooks · doi:10.1007/978-1-4471-3666-8_39 · Cited by 5

Thrombose de la veine cave inférieure sur syndrome primaire des antiphospholipides : à propos d’un cas

Berrady, R., Khammar, Z., Lamchachti, L., Lahlou, M., Rabhi, S., & Bono, W. (2009) · Journal des Maladies Vasculaires · doi:10.1016/j.jmv.2009.11.004 · Cited by 4

Perioperative bridging therapy with low molecular weight heparin for patients with inherited thrombophilia and antiphospholipid syndrome on long-term acenokumarol therapy

Wiszniewski, A., Szopiński, P., Ratajczak, J., Bilski, R., & Bykowska, K. (2010) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e328340e690 · Cited by 4

Thromboses veineuses des membres inférieurs

Élias, A., & Boccalon, H. (2006) · EMC - Angéiologie · doi:10.1016/s1290-0176(06)74132-1 · Cited by 4

Recurrence risk of idiopathic venous thromboembolism

Franco‐Moreno, A., Aracil, C. D. A., & Navarro, M. J. G. (2016) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2016.06.002 · Cited by 4

Antiphospholipid antibodies and stroke†

SHANAHAN, J., & Ortel, T. L. (2002) · Seminars in Cerebrovascular Diseases and Stroke · doi:10.1053/scds.2002.124067 · Cited by 4

Antiphospholipid syndrome: why and how should we make the diagnosis?

Sibilia, J. (2003) · Joint Bone Spine · doi:10.1016/s1297-319x(03)00014-9 · Cited by 4

Durée du traitement anticoagulant oral dans la maladie thromboembolique veineuse

Pinède, L. (2001) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(01)00494-5 · Cited by 4

Facteurs de risque de récidive de la maladie thromboembolique veineuse

Rosencher, J., Mirault, T., Martínez, I. S., Zhu, T., Messas, E., & Emmerich, J. (2011) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2010.10.036 · Cited by 6

Transmetatarsal Amputation in the Setting of Antiphospholipid Antibody Syndrome

McLeod, J. M., Brantigan, C. O., Alix, K., Kruse, D. L., & Stone, P. A. (2013) · The Journal of Foot & Ankle Surgery · doi:10.1053/j.jfas.2013.02.011 · Cited by 4

Treatment of antiphospholipid antibody syndrome

Mehdi, A. A., Uthman, I. W., & Khamashta, M. A. (2010) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.10.8 · Cited by 4

Secondary Omental Infarction in a Patient with a Hypercoagulable State

Alshehri, M., Khalifa, H., Alqahtani, A., & Aburahmah, M. (2018) · BMJ Case Reports · doi:10.1136/bcr-2017-223212 · Cited by 4

The Antiphospholipid Syndrome: Clinical Presentation, Diagnosis, and Patient Management

Rand, J. H., Levin, M. B., & Alving, B. M. (2007) · Elsevier eBooks · doi:10.1016/b978-141602401-9.10019-7 · Cited by 4

Management of Thrombosis in Antiphospholipid Syndrome

Khamashta, M. A., & Ruiz‐Irastorza, G. (2006) · Springer eBooks · doi:10.1007/1-84628-009-5_43 · Cited by 4

Trombofilie: risicofactoren voor veneuze trombo-embolie

Middeldorp, S. (2004) · Bijblijven · doi:10.1007/bf03059815 · Cited by 4

Duration of anticoagulant therapy for patients with venous thromboembolism

Garcia, D. A. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2008.08.019 · Cited by 4

Management of Thrombocytopenia in Hughes Syndrome

Galli, M., & Barbui, T. (2006) · Springer eBooks · doi:10.1007/1-84628-009-5_45 · Cited by 4

Wound, pressure ulcer, and burn guidelines (2023)―4: Guidelines for the management of connective tissue disease/vasculitis‐associated skin ulcers, third edition

Asano, Y., Asai, J., Ishii, T., Iwata, Y., Kodera, M., Miyabe, C., Uchiyama, A., Ogawa, Y., Okamura, K., Kishibe, M., et al. (2025) · The Journal of Dermatology · doi:10.1111/1346-8138.17703 · Cited by 3

Durée optimale du traitement anticoagulant au décours d’une maladie veineuse thrombo-embolique

Savina, E. N., & Couturaud, F. (2011) · Journal des Maladies Vasculaires · doi:10.1016/s0398-0499(11)70005-1 · Cited by 3

Rethinking the use of direct oral anticoagulants for secondary thromboprophylaxis in patients with thrombotic antiphospholipid syndrome

Franco‐Moreno, A., Izquierdo-Martínez, A., & Aracil, C. D. A. (2024) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2024.01050 · Cited by 3

Identification of phenotypes in thrombotic primary antiphospholipid syndrome using cluster analysis: a step toward personalized medicine

Santos, G. M., David, P., Hen, O., Ontiveros-Austria, J. L., Liran, R., Rodríguez‐Rodríguez, S., de Godói, J. C., Patt, Y. S., Beladev, S., Okazaki, E., et al. (2025) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2025.06.010 · Cited by 3

Association between elevated plasma levels of factor VIII and risk of recurrent venous thromboembolism: a systematic review and meta-analysis

Teymoori, S., Dezfouli, M., Feizi, A., Hashemi, H., & Shirzadi, M. (2025) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-025-03161-8 · Cited by 4

Duration of anticoagulation treatment in patients with venous thromboembolism.

Kaatz, S., Qureshi, W., Fain, C., & Paje, D. G. (2010) · PubMed · Cited by 3

G ENETIC S USCEPTIBILITY TO V ENOUS T HROMBOSIS

Eligsohn, U. R. S., & Ubetsky, A. H. L. (2001) · Cited by 3

A review on management of antiphospholipid syndrome in clinical practice

Siniscalchi, C., Rossetti, P., Carolla, G., Micco, P. D., Stella, A., & Riva, M. A. (2023) · Italian Journal of Medicine · doi:10.4081/itjm.2023.1649 · Cited by 3

Cerebral venous thrombosis: Incidence in prothrombotic states

DiPaola, J. (2002) · Seminars in Cerebrovascular Diseases and Stroke · doi:10.1053/scds.2002.32657 · Cited by 3

Usefulness of a Diluted Prothrombin Time for Accurately Diagnosing Antiphospholipid Syndrome

Nakai, K., Wada, H., Nakatani, K., Kamikura, Y., Mastumoto, T., Kobayashi, T., Tonomura, H., Tono, Y., Ohyabu, M., Ota, S., et al. (2009) · Vascular Disease Prevention · doi:10.2174/1567270000906010025 · Cited by 3

Viewpoint: Provoked thrombosis in antiphospholipid syndrome

Wahl, D. G., & Pengo, V. (2024) · Rheumatology · doi:10.1093/rheumatology/kead675 · Cited by 3

Clinical Management of Antiphospholipid Syndrome-Related Thrombosis~!2009-09-14~!2009-09-17~!2010-03-11~!

Espinosa, G., & Cervera, R. (2010) · The Open Autoimmunity Journal · doi:10.2174/1876894601002020067 · Cited by 3

Arterial thrombosis associated with adjuvant chemotherapy for breast cancer: A case report

Bourdeanu, L., & Luu, T. H. (2010) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2009.00486.x · Cited by 3

The use of laboratory methods in differential diagnosis and treatment of SLE and antiphospholipid syndrome

Alba, P. B., Bertolaccini, M. L., & Khamashta, M. A. (2007) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.3.4.613 · Cited by 3

Antiphospholipid Syndrome

Rand, J. H., & Wolgast, L. R. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2296-9.00020-8 · Cited by 3

Antiphospholipidsyndrom

Specker, C. (2006) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-006-0127-3 · Cited by 3

Optimizing the duration of anticoagulation therapy for venous thrombosis.

Solymoss, S. (1999) · Europe PMC (PubMed Central) · Cited by 3

Durée optimale du traitement anticoagulant au décours d’un épisode de maladie veineuse thromboembolique

Couturaud, F., & Kearon, C. (2008) · Revue de Pneumologie Clinique · doi:10.1016/j.pneumo.2008.09.007 · Cited by 3

The clinical significance of antiphospholipid antibodies in patients without autoimmune disease

Brighton, T., & Chesterman, C. N. (2000) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.2000.tb04364.x · Cited by 3

Myocardial infarction in an 11-year-old child with systemic lupus erythematosus

Bilici, M. (2016) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2016.7021 · Cited by 3

Course and Prognosis of the Antiphospholipid Syndrome

Drenkard, C., & Alarcón-Segovia, D. (2002) · Elsevier eBooks · doi:10.1016/b978-044450987-1/50037-1 · Cited by 3

Management of the Difficult Aspects of the Antiphospholipid Syndrome

Erkan, D., Sammaritano, L. R., & Lockshin, M. D. (2002) · Elsevier eBooks · doi:10.1016/b978-044450987-1/50036-x · Cited by 3

Antiphospholipid syndrome: treatment controversies

Ruiz‐Irastorza, G., & Khamashta, M. A. (2006) · Future Rheumatology · doi:10.2217/17460816.1.3.345 · Cited by 3

Current Management of Acute Symptomatic Deep Vein Thrombosis

Heit, J. A. (2001) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200101010-00005 · Cited by 3

Tratamiento del síndrome antifosfolipídico, ¿a quién, cuándo y cuánto tiempo?

Castañeda, M. C. A. (2005) · Reumatología Clínica · doi:10.1016/s1699-258x(05)72773-x · Cited by 2

Radiofrequency radiation exposure and other environmental concerns.

House, R. A. (1999) · Europe PMC (PubMed Central) · Cited by 2

Group A streptococcal necrotizing fasciitis of the psoas muscle

Anderson, J. F., & Cunha, B. A. (1999) · Heart & Lung · doi:10.1016/s0147-9563(99)70062-2 · Cited by 2

Antiphospholipid antibody syndrome—an overview

Sridevi, C., & Raju, P. K. (2011) · Journal of Indian College of Cardiology · doi:10.1016/s1561-8811(11)80022-2 · Cited by 2

An update on current management strategies for antiphospholipid syndrome‑related thrombosis

Rossi, A., Colorio, C. C., Puente, D., & Forastiero, R. R. (2014) · Clinical Lipidology · doi:10.2217/clp.13.85 · Cited by 3

Riesgo de recurrencia en el tromboembolismo venoso idiopático

Franco‐Moreno, A., Aracil, C. D. A., & Navarro, M. J. G. (2016) · Revista Clínica Española · doi:10.1016/j.rce.2016.04.015 · Cited by 2

Management of the Antiphospholipid Syndrome

Erkan, D., & Roubey, R. A. S. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-9993-2.00011-4 · Cited by 2

Syndrome des antiphospholipides : pourquoi faut-il y penser et comment faire le diagnostic ?

Sibilia, J. (2003) · Revue du Rhumatisme · doi:10.1016/s1169-8330(03)00057-7 · Cited by 2

Diagnosis of antiphospholipid syndrome

Bertolaccini, M. L., & Khamashta, M. A. (2008) · Expert Review of Hematology · doi:10.1586/17474086.1.2.183 · Cited by 2

Management of acquired thrombophilic disorders in 2011: focus on heparin-induced thrombocytopenia, antiphospholipid syndrome, myeloproliferative neoplasms and paroxysmal nocturnal hemoglobinuria.

Emadi, A., & Streiff, M. B. (2011) · PubMed · Cited by 2

Management of Thrombophilia and Antiphospholipid Syndrome During Pregnancy

Kujovich, J. L., & Alving, B. M. (2007) · Elsevier eBooks · doi:10.1016/b978-141602401-9.10036-7 · Cited by 2

Antiphospholipid/Endothelial Cell Interaction in the Pathogenesis of the Antiphospholipid Syndrome

Meroni, P. L., Raschi, E., Testoni, C., Tincani, A., Balestrieri, G., & Youinou, P. (2002) · Elsevier eBooks · doi:10.1016/b978-044450987-1/50010-3 · Cited by 2

Antiphospholipid antibody syndrome (Hughes' syndrome)

Francès, C., & Pietté, J. C. (2001) · Dermatologic Therapy · doi:10.1046/j.1529-8019.2001.014002117.x · Cited by 2

Two cases of catastrophic antiphospholipid syndrome

Navarrete, N., Macias, P., Jaén, F., Hidalgo, C., Cáliz, R., & Jiménez-Alonso, J. F. (2005) · Lupus · doi:10.1191/0961203305lu2167cr · Cited by 2

Lessons from Sequence Analysis of Monoclonal Antiphospholipid Antibodies

Giles, I., Isenberg, D. A., & Rahman, A. (2006) · Springer eBooks · doi:10.1007/1-84628-009-5_38 · Cited by 2

Prevention of recurrent thrombosis in the antiphospholipid antibody syndrome: how long and how high with oral anticoagulant therapy?

Baker, R. I. (2004) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2004.tb06015.x · Cited by 2

Management of Thrombocytopenia in Hughes Syndrome

Galli, M., & Barbui, T. (2000) · Springer eBooks · doi:10.1007/978-1-4471-3666-8_41 · Cited by 2

Management of Thrombosis in the Antiphospholipid Syndrome

Derksen, R. H. W. M., de Groot, P. G., & Brey, R. L. (2002) · Elsevier eBooks · doi:10.1016/b978-044450987-1/50034-6 · Cited by 2

Recurrent Thrombosis in Patients with Deep Vein Thrombosis and/or Venous Thromboembolism Associated with Anticardiolipin Antibodies

de Godoy, J. M. P., de Godoy, M. F., & Braile, D. M. (2006) · Angiology · doi:10.1177/000331970605700111 · Cited by 23

Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment.

Derksen, R. H. W. M., de Groot, P. G., Kater, L., & Nieuwenhuis, H. K. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.9.689 · Cited by 240

Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review

Garcia, D. A., Akl, E. A., Carr, R., & Kearon, C. (2013) · Blood · doi:10.1182/blood-2013-04-496257 · Cited by 135

The effect of the duration of anticoagulation and other risk factors on the recurrence of venous thromboembolisms. Duration of Anticoagulation Study Group.

Schulman, S. (1999) · PubMed · Cited by 37

Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal.

Asherson, R. A., Chan, J. K., Harris, E. N., Gharavi, A. E., & Hughes, G. R. V. (1985) · Annals of the Rheumatic Diseases · doi:10.1136/ard.44.12.823 · Cited by 130